Indication
Muckle-Wells syndrome
Muckle-Wells syndrome is a rare, autosomal dominant autoinflammatory disorder that represents an intermediate phenotypic severity within the spectrum of cryopyrin-associated periodic syndromes. Read more about Muckle-Wells syndrome
5 drugs 4 manufacturers
Drugs that treat it
Common Muckle-Wells syndrome therapies.
ILARIS (canakinumab/PF)
ARCALYST (rilonacept)
ILARIS (PF) (canakinumab/PF)
ILARIS (canakinumab/PF)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMuckle-Wells syndrome is a rare, autosomal dominant autoinflammatory disorder that represents an intermediate phenotypic severity within the spectrum of cryopyrin-associated periodic syndromes.
Pathophysiologically, it is driven by gain-of-function mutations in the *NLRP3* (*CIAS1*) gene, which causes hyperactivation of the NLRP3 inflammasome and uncontrolled overproduction of interleukin-1 beta.
Manifesting from infancy or early childhood, the disease is characterized by recurrent systemic inflammatory flares featuring urticaria-like rashes, fevers, arthralgias, and conjunctivitis.
Chronic systemic inflammation frequently leads to progressive complications in adolescence and adulthood, predominantly progressive sensorineural hearing loss and secondary systemic AA amyloidosis that often precipitates renal failure.
- nih.gov
Muckle-Wells syndrome is a rare, autosomal dominant autoinflammatory disorder that represents an intermediate phenotypic severity within the spectrum of cryopyrin-associated periodic syndromes Pathophysiologically, it is driven by gain-of-function mutations in the *NLRP3* (*CIAS1*) gene, which causes hyperactivation of the NLRP3 inflammasome and uncontrolled overproduction of interleukin-1 beta Manifesting from infancy or early childhood, the disease is characterized by recurrent systemic inflam...
- webmd.com
Muckle-Wells syndrome is a rare, autosomal dominant autoinflammatory disorder that represents an intermediate phenotypic severity within the spectrum of cryopyrin-associated periodic syndromes Pathophysiologically, it is driven by gain-of-function mutations in the *NLRP3* (*CIAS1*) gene, which causes hyperactivation of the NLRP3 inflammasome and uncontrolled overproduction of interleukin-1 beta Manifesting from infancy or early childhood, the disease is characterized by recurrent systemic inflam...
- nomidalliance.org
Muckle-Wells syndrome is a rare, autosomal dominant autoinflammatory disorder that represents an intermediate phenotypic severity within the spectrum of cryopyrin-associated periodic syndromes
- medlineplus.gov
Manifesting from infancy or early childhood, the disease is characterized by recurrent systemic inflammatory flares featuring urticaria-like rashes, fevers, arthralgias, and conjunctivitis Chronic systemic inflammation frequently leads to progressive complications in adolescence and adulthood, predominantly progressive sensorineural hearing loss and secondary systemic AA amyloidosis that often precipitates renal failure
Personalize your experience
Follow Muckle-Wells syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.